Form 4 for BSX Boston Scientific
Accepted 2025-02-12 00:00:00 ET · period of report 2025-02-11 · accession 0001225208-25-001594 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-12 | 2025-02-11 | BSX | LUDWIG EDWARD J | Dir | S - Sale | $105.48 | -12.0K | 24.4K | -33% | -$1.27M | |
| 2025-02-12 | 2025-02-11 | BSX | LUDWIG EDWARD J | Dir | G - Gift | $0.00 | -3,000 | 36.4K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-11 | S | D | 12,000 | $105.48 | 24,398 | D | — | — | (F1) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $105.47 to $105.55, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2025-02-11 | G | D | 3,000 | $0.00 | 36,398 | D | — | — |